Page last updated: 2024-09-02

ecteinascidin 743 and Anemia, Fanconi

ecteinascidin 743 has been researched along with Anemia, Fanconi in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albella, B; Aracil, M; Bueren, JA; Gago, F; Galmarini, CM; Martínez, S; Pérez, L; Tercero, JC1
Albella, B; Bueren, JA; Casado, JA; Domingo, A; Gago, F; García-Hernández, V; Marco, E; Pérez, L; Río, P; Tercero, JC; Vaquero, JJ1

Other Studies

2 other study(ies) available for ecteinascidin 743 and Anemia, Fanconi

ArticleYear
Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.
    British journal of pharmacology, 2013, Volume: 170, Issue:4

    Topics: Animals; Antineoplastic Agents; Binding Sites; Carbolines; Cell Line, Tumor; Dioxoles; DNA; Dose-Response Relationship, Drug; Fanconi Anemia; Fanconi Anemia Complementation Group Proteins; Hematopoietic Stem Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Transgenic; Mitomycin; Neoplasms; Signal Transduction; Tetrahydroisoquinolines; Trabectedin

2013
Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Cell Cycle; Dioxoles; DNA; DNA Breaks, Double-Stranded; DNA Repair; Dose-Response Relationship, Drug; Fanconi Anemia; Fanconi Anemia Complementation Group Proteins; Humans; Mitomycin; Tetrahydroisoquinolines; Time Factors; Trabectedin

2008